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Abstract
Lipid rafts and caveolae are cholesterol- and sphingolipid-rich microdomains of the plasma
membrane that concentrate components of certain signal transduction pathways. Interest in and
exploration of these microdomains has grown in recent years, especially following the discovery
of the biochemical marker of caveolae, caveolin, and the recognition that caveolin interacts with
many different signaling molecules via its scaffolding domain. There are 3 major types of
caveolins (1, 2, and 3) with some selectivity in their expression in different tissues. Results
assessing lipid raft/caveolae co-localization of molecules in signal transduction pathways
provided support for the idea that signaling components are compartmentalized or pre-assembled
together. This chapter describes non-detergent and detergent-based methods for isolating lipid
rafts and caveolae for biochemical studies. We also describe a method for immunoisolation
(using antibodies to caveolins) of detergent-insoluble membranes that selectively isolates
caveolae versus lipid rafts. Together, these methods are useful for assessment of the role of lipid
rafts and caveolae in transmembrane signaling.

Key words: lipid rafts, caveolae, membrane microdomains, plasma membrane vesicles, density
gradient centrifugation, immunoprecipitation, immunoisolation.
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1. Introduction
Recent investigations have identified caveolae and lipid rafts as important microdomains
of the plasma membrane that concentrate and perhaps “pre-assemble” the components of signal
transduction pathways [1, 2]. The enrichment of a large array of signal transduction components
in those domains [3] suggests that caveolae and lipid rafts are signaling centers, whose role in
physiologic and pathophysiologic processes is the subject of intense investigation. Caveolae
(“little caves”) were morphologically identified in the 1950’s as flask-like, 50-100 nm
invaginations of the plasma membrane of endothelial cells and later shown to be involved in
potocytosis, endocytosis and transcellular movement of molecules [4, 5]. Endocytosis by
caveolae differs from that mediated by another specialized region of the plasma membrane,
clathrin-coated pits. These two vesicular structures differ biochemically and transport different
types of molecules, and thus represent parallel but distinct pathways [5].
Lipid rafts form via the coalescence of particular lipids, most prominently sphingolipids
and cholesterol (12). Caveolae have a similar lipid composition to rafts but also contain a “coat”
of caveolin proteins on the inner leaflet of the membrane bilayer [6]. While all mammalian cells
appear to contain plasma membrane lipid rafts [7], only cells expressing caveolins express
caveolae (for example, leukocytes contain lipid rafts but no caveolae). There are 3 isoforms of
caveolin, caveolin-1, caveolin-2, and caveolin-3; caveolae can form if cells express either
caveolin-1, the predominant isoform, or caveolin-3, the striated muscle-specific isoform [8, 9].
Caveolin-2 does not appear to induce caveolae formation, but is found in hetero-oligomers with
caveolin-1 and caveolin-3 [10-14]. Although caveolae are generally considered subsets of lipid
rafts due to their similar lipid composition, the two entities likely differ in a variety of ways [1517]. By their original definition, caveolae are discrete morphologic structures identifiable at the
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electron microscopic level, however lipid rafts cannot readily be identified by microscopic
techniques (except by atomic force microscopy [18]).
Lipid rafts and caveolae are most readily studied with biochemical approaches. Cells are
disrupted and the lipid rafts and caveolae are then extracted from other cellular material,
generally based upon their relative insolubility and buoyancy in certain detergent or nondetergent conditions. Most commonly, lipid rafts and caveolae are isolated by virtue of their
high buoyancy when centrifuged on a density gradient consisting of either a discontinuous
gradient of sucrose [5, 19-21], as we describe here, or a continuous gradient of Optiprep, as
described elsewhere [22, 23]. These approaches, which rely upon properties common to both
lipid rafts and caveolae, do not distinguish between these domains. Caveolae can be
preferentially isolated from lipid rafts, however, using immunological approaches to trap
caveolin-rich membrane domains [24, 25]. We describe one general method for isolating
caveolae from cells and tissues in this chapter. Another method developed by Oh and Schnitzer
isolates caveolae using immunoisolation of caveolin; this method is particularly suitable for cells
or tissues with high levels of expression of caveolins and caveolae, such as pulmonary vascular
endothelia [24].
Caveolins can also act as scaffolding proteins, whereby other proteins, including proteins
involved in signal transduction, bind; such binding generally is associated with an inhibition in
signaling activity [2]. Immunoprecipitation of caveolin proteins or expression of peptides that
interfere with the caveolin-binding motif, the domain on caveolin-1 and caveolin-3 that binds
those other proteins [2], can be used to assess the role of the putative caveolin scaffold. Caveolin
protein overexpression and knockout has also been used to examine the role of these proteins in
physiology and signal transduction [26]. Because caveolins act as regulators of several signal

4

transduction pathways [6], alteration in their expression by such approaches cannot be
considered a pure “probe” of the compartmentation of a particular signaling pathway in caveolae.
The function of lipid rafts and caveolae in signaling or other cellular processes can also be
inferred from studies in which the microdomains are disrupted. Methyl-ß-cyclodextrin, a
chemical that does not enter cells but can bind cholesterol and remove it from the plasma
membrane, disrupts lipid rafts and caveolae [27]. Filipin, a polyene antibiotic and sterol-binding
agent, also disrupts lipid rafts and caveolae [28, 29]. This chapter does not describe these
methodologies but interested readers may wish to consult articles describing their use [19, 28,
30].
Microscopic studies are useful and sometimes important for corroboration of results from
biochemical studies of lipid rafts and caveolae. However, such approaches, not described here,
are limited by their inability to detect lipid rafts (as noted above), the poor resolution of light and
fluorescent microscopy for the identification of caveolae, and the variable ability and availability
of suitable antibodies to detect the proteins of interest. With suitable antibodies, one can assess
protein localization using double immunostaining and electron microscopy. Cholera toxin,
which binds to GM1 ganglioside enriched in lipid rafts [28], can be used as a marker of lipid
rafts and caveolae while caveolin can be used as a marker of caveolae. Atomic force
microscopy, which can detect the surface topology of cell membranes, is a technique with future
promise for visualizing lipid rafts [18]. Other technologies, such as fluorescence resonance
energy transfer (FRET) and bioluminescence energy transfer (BRET), are powerful tools for
examination of interaction of components but their use is limited to the examination of
exogenously expressed proteins with fluorescent/luminescent tags [31].
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In this chapter, we describe non-detergent and detergent-based methods for isolating lipid
rafts/caveolae and caveolae. We describe some variations of this general approach that can be
useful in specific circumstances and we present complementary methods to address the question
of signaling in lipid rafts or caveolae. We also describe a method for immunoisolation of
detergent-insoluble membranes that selectively isolates caveolae versus lipid rafts. Each method
has advantages and disadvantages that should be considered when choosing an experimental
approach to answer a particular biological question. Non-detergent fractionation of cells retains
certain proteins in lipid raft/caveolar fractions that can be lost upon detergent solubilization [22,
32]. On the other hand, detergent-based approaches can allow the measurement of protein
function, such as enzyme activity, while the non-detergent methods (due to high pH and high
energy sonication) do not. We believe that it is generally desirable to use a combination of
different, complementary approaches, along with immunoprecipitation (i.e. “pull-down” of
proteins in detergent conditions that solubilize all membrane proteins, [not described herein]) to
assess protein-protein interactions, in order to study signal transduction in lipid rafts and
caveolae.

2. Materials
1.

PBS: phosphate buffered saline

2.

500 mM Na2CO3 (should be approximately pH 11, but do not adjust).

3.

MBS: 25 mM MES, 150 mM NaCl, pH 6.0.

4.

MBS/Na2CO3: MBS, 250 mM Na2CO3.

5.

90% Sucrose/MBS: dissolve 45g sucrose with MBS until volume equals 50 ml. Heat in
a microwave oven (in 10 sec intervals) to dissolve/melt.
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6.

35% Sucrose in MBS/Na2CO3: 5.83 mL 90% Sucrose/MBS plus 9.17 mL MBS/Na2CO3.

7.

5% Sucrose in MBS/Na2CO3: 0.83 mL 90% Sucrose/MBS plus 14.17 mL
MBS/Na2CO3.

8.

Triton X-100 Buffer: MBS, 1% Triton X-100, protease inhibitor mix (Sigma P-8340,
diluted 1:100).

9.

35% Sucrose in MBS/Triton X-100: 5.83 mL 90% Sucrose/MBS plus 9.17 mL Triton X100 buffer.

10. 5% Sucrose in MBS/Na2CO3: 0.83 mL 90% Sucrose/MBS plus 14.17 mL Triton X-100
buffer.
11. Membrane Buffer: 0.25 M sucrose, 1 mM EDTA, 20 mM Tricine, pH 7.8
12. 30% Percoll: 3 mL Percoll stock solution diluted in 9 mL PBS.
13. Modified Lysis Buffer: 50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1 mM EGTA, 10 mM
MgCl2, 0.5% Triton X-100, protease inhibitor mix (Sigma P-8340, diluted 1:100).
14. Protein A-agarose and protein G-agarose
15. Immunoprecipitation (IP) Wash Buffer 1: 50 mM Tris-HCl, pH 7.5, 500 mM NaCl,
0.2% Triton X-100.
16. IP Wash Buffer 2: 10 mM Tris-HCl, pH 7.5, 0.2% Triton X-100.
3. Methods
3.1

Isolation of lipid rafts and caveolae by sucrose density centrifugation

This method relies upon the unique lipid composition (with enrichment in sphingolipid and
cholesterol) of lipid rafts and caveolae, which makes these membrane domains resistant to
solubilization in certain conditions as well as more buoyant than other cellular lipids. We
describe the method for adherent cells in tissue culture but it can be readily adapted for cells in
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suspension or for tissue samples. We have found that two 150 mm plates of cells is adequate for
one preparation.
3.1.1

Sodium carbonate isolation of lipid rafts and caveolae.

1. Check that cells are at least 70% confluent. One preferably grows cells on 150 mm tissue
culture plates (dishes) to optimize the amount of starting material. Aspirate medium and
wash 3 times with ice-cold PBS. On the last wash, be sure to remove all PBS by tilting
the plate at a steep angle for 30 sec then aspirating all liquid.
2. Apply 1mL of 500 mM Na2CO3 to each 150 mm plate and make sure it covers the entire
monolayer. Scrape cells from the plate with a cell scraper, making sure to retain as much
cellular material as possible.
3. Transfer the cells from two plates (2 mL total) to a pre-chilled Dounce (glass-glass)
homogenizer and homogenize the cells with 20 strokes on ice.
4. Transfer the homogenate to a cold 50 ml Falcon tube and homogenize with a polytron 3
times for 10 seconds with intervals of 10-15 sec. Rinse the polytron blade with 0.5 ml of
500 mM Na2CO3 into the sample to recover all possible material.
5. Homogenize the sample using an ultrasonic cell disruptor equipped with a stainless steel
probe at high power 3 times for 20 sec each with a full 60 sec rest between each
homogenization.
6. Proceed to section 3.1.4.
3.1.2

Detergent isolation of lipid rafts and caveolae

1. Check that cells are at least 70% confluent. Aspirate medium and wash 3 times with icecold PBS. On the last wash, be sure to remove all PBS by tilting the plate at a steep angle
for 30 sec and then aspirating all liquid.
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2. Apply 1mL of 1% Triton-X 100 buffer to each 150 mm plate so that it covers the entire
monolayer (see Note 1). Scrape cells from the plate with a cell scraper making sure to
retain as much cellular material as possible.
3. Transfer the cells from two plates (2 mL total) to a pre-chilled Dounce (glass-glass)
homogenizer and incubate on ice for 20 min. Homogenize the cells with 20 strokes on
ice.
4. Proceed to section 3.1.4.
3.1.3

Variation: Isolation of lipid rafts and caveolae from plasma membranes

1. Check that cells are at least 70% confluent. Aspirate medium and wash 3 times with icecold PBS. On the last wash, be sure to remove all PBS by tilting the plate at a steep angle
for 30 sec and then aspirating all liquid.
2. Apply 1mL of Membrane buffer to each 150 mm plate so that it covers the entire
monolayer. Scrape cells from the plate with a cell scraper making sure to retain as much
cellular material as possible.
3. Collect the cells from two plates (2 mL total) and homogenize cells with 20 strokes in a
Dounce (glass-glass) or Teflon-glass homogenizer on ice then centrifuge at 300g for 5
min and collect the supernatant.
4. Layer the supernatant on top of 30% Percoll and centrifuge at 64,000g (19,000 rpm on a
SW41 rotor for a Beckman ultracentrifuge) for 30 min.
5. Collect the opaque band near the top of the Percoll layer as plasma membrane (PM).
6. Adjust PM to 500 mM Na2CO3 by adding an equal volume of 1 M Na2CO3 and sonicate 3
times for 20 sec with full 60 sec rests between intervals.
3.1.4

Sucrose density centrifugation to fractionate cell homogenates
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Once cells or tissues are homogenized using one of the above approaches (3.1.1, 3.1.2 or
3.1.3), the lipid raft/caveolar fraction can be isolated using sucrose density centrifugation.
As explained above, this method relies upon the unique lipid composition of the lipid
raft/caveolae (rich is sphingolipid and cholesterol), which makes these domains of the
membrane more buoyant than other cellular components. A schematic diagram of this
fractionation, as shown in Figure 1 and as described subsequently, involves use of a
discontinuous gradient, although a continuous gradient can also be employed.
1. Mix 2.0 mL of homogenized sample (leaving any foam behind) with 2.0 mL of 90%
sucrose/MBS in an ultracentrifuge tube. Save any remaining sample as whole cell lysate.
2. Carefully layer 4 mL of either 35% Sucrose in MBS/Na2CO3 (if sample was
homogenized by non-detergent method, Sections 3.1.1 or 3.1.3) or 35% Sucrose in
MBS/Triton X-100 Buffer (if sample was homogenized by detergent method, Section
3.1.2) on top of the sample/90% sucrose/MBS layer. A visible interface should exist
between the two density layers.
3. Carefully layer 4 mL of either 5% Sucrose in MBS/Na2CO3 (if sample was homogenized
by non-detergent method, Sections 3.1.1 or 3.1.3) or 5% Sucrose in MBS/Triton X-100
Buffer (if sample was homogenized by detergent method, Section 3.1.2) on top of the
35% sucrose layer. A second interface should be visible between the 35% sucrose and
the 5% sucrose layers and the ultracentrifuge tube should be nearly full.
4. Centrifuge for 16-20 hours at 39,000rpm (4˚C) in SW41Ti rotor (Beckman), equivalent to
a maximum force (bottom of tube) of approximately 260,000 x g and an average force
(middle of the tube) of approximately 188,000 x g (see Note 2).
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5. At the completion of the centrifugation, carefully remove the ultracentrifuge tube from
the bucket. A faint light-scattering band, which consists of the buoyant lipid raft/caveolar
material, is often visible at the 35% sucrose-5% sucrose interface.
6. Collect samples from the gradient from the top down as 1 ml fractions, being careful to
keep the pipet at the top of the liquid in order to draw each fraction appropriately.
7. Fractions can then be analyzed by SDS-PAGE and immunoblotting (see Note 3).

3.2 Immunoisolation of caveolae
With this method, one takes advantage of the reduced solubility of lipid rafts and caveolae
to detergent in order to isolate these domains from the rest of the cellular material (as in section
3.1.2) and one then selectively “traps” caveolae (vs. lipid rafts) by using an antibody to
immunoprecipitate caveolin (and associated lipids and proteins). Antibodies to any of the
caveolin isoforms can be used, but these should be chosen carefully based upon expression of
caveolins in the cell or tissue of interest. With this method one has the potential to maintain
enzyme and receptor binding activity, thus allowing one to assess protein function. We have
used this approach to assay receptor-activated adenylyl cyclase activity in caveolae from cardiac
myocytes [25] and other cells, thus the function of other proteins are likely also maintained.
1. Check that cells are at least 70% confluent. Aspirate medium and wash 3 times with icecold PBS. On the last wash, be sure to remove all PBS by tilting plate at a steep angle for
30 sec and then aspirating all liquid.
2. Add 2 ml of Modified Lysis Buffer to each 15 cm plate. Homogenize cells with 20
strokes in a Dounce (glass-glass) homogenizer.
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3. Transfer to a 1.5 ml microtube and add 50 µl of either protein G- or Protein A-agarose
suspension (see Note 4). Incubate at 4˚C on a rocking platform for 1 hr.
4. Centrifuge in a micro centrifuge at max speed (12,000 to 14,000 rpm) for 30 sec to pellet
agarose and then transfer the supernatant to a new tube.
5. Add primary antibody (1-3 µl, depending on the antibody concentration) and gently mix
(preferably by rocking) at 4˚C for 1 hr.
6. Add 50 µl protein A- or protein G-agarose to tube and incubate at 4˚C on a rocking
platform for 1 hr.
7. Centrifuge in a micro centrifuge at max speed (12,000 to 14,000 rpm) for 30 sec to pellet
agarose. Supernatant should be saved as the IP supernatant and used as a control.
8. Add 1 ml of Modified Lysis Buffer to pellet, mix and rock at 4˚C for 5 min.
9. Centrifuge in a micro centrifuge at max speed (12,000 to 14,000 rpm) for 30 sec to pellet
agarose, remove supernatant and add 1 ml of Wash Buffer 1 to pellet, mix and rock at
4˚C for 5 min.
10. Centrifuge in a micro centrifuge at max speed (12,000 to 14,000 rpm) for 30 sec to pellet
agarose, remove supernatant and add 1 ml of Wash Buffer 2 to pellet, mix and rock at
4˚C for 5 min.
11. The final pellet should then be suspended in a suitable assay buffer (if enzyme activity is
to be measured) and/or in sample buffer for analysis by SDS polyacrylamide gel
electrophoresis (for immunoblotting). Immunoblot analysis should be performed on a
portion of the immunoprecipitated pellet and supernatants to confirm appropriate
immunoprecipitation and to assess which proteins have been co-precipitated with the
target protein.
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4. Notes
1. Non-ionic detergents other than Triton X-100, including NP-40, octylglucoside, CHAPS,
Lubrol, and Brij 98, can be used to solubilize cells and isolate lipid raft and caveolar
domains [19]. In addition, some investigators have used concentrations of Triton X-100
lower than 1% in protocols similar to that described above.
2. Other rotors can be used for the sucrose density centrifugation, including a Beckman
SW55Ti rotor with 5 ml buckets. In this case 1 ml of cell homogenate is mixed with 1 ml
90% sucrose and 2 ml of 35% sucrose and 1 ml 5% sucrose is layered on top. The
rotation speed is adjusted to maintain equivalent g forces. Fractions are collected in 0.5
ml aliquots to yield 10 fractions.
3. It is critical to determine the appropriateness of each fractionation by performing
immunoblot analysis for markers of cellular organelles. Fractions from the 5%
sucrose/35% sucrose interface (numbers 4 and 5) should contain the bulk of any caveolin
immunoreactivity but exclude markers of clathrin-coated pits (such as adaptin-ß), Golgi
apparatus (such as mannosidase II) and other cellular organelles for the markers
discussed above. The total protein in each fraction can also be used as an indicator of
appropriate fractionation. The buoyant fractions from most cells contain approximately
5% or less of the total cellular protein. Individual fractions from the gradient can be
pooled into a buoyant fraction (collected from the 5%-35% sucrose interface) and a nonbuoyant fraction (consisting of the entire 45% sucrose layer), if desired, in order to
facilitate rapid screening of antibodies. This approach simplifies immunoblot analysis
when the localization of many different proteins needs to be assessed. However, it is
wise to collect individual fractions as described above and then to combine a portion of
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these fractions to form pooled fractions, saving some portion of the individual fractions at
–70˚ C for future use. See Figure 1. When immunoblot analysis of fractions is planned,
it is best to add SDS-PAGE sample buffer to each fraction and to denature at -70˚C for 10
min immediately after collecting the gradient. This will ensure more reproducible results
when storing frozen samples for extended periods. For detection of low abundance
proteins, samples can also be concentrated in Speed-vac (or similar type) concentrator
before addition of sample buffer. However, the fractions from the bottom of the gradient
will not concentrate as well because of the presence of higher concentrations of sucrose.
Dialysis can also be used to remove sucrose and to concentrate the samples.
4. When performing any type of immunoprecipitation, one should carefully choose between
protein A-agarose and protein G-agarose for precipitation of the primary antibody.
Protein A has high affinity for human, rabbit, guinea pig and pig IgG’s and moderate
affinity for mouse, horse and cow IgG’s. Protein G has high affinity for human, horse,
cow, pig and rabbit IgG’s and moderate affinity for sheep, goat, chicken, hamster, guinea
pig, rat and mouse IgG’s. Protein A and protein G also differ in their affinities for
different subclasses of IgG’s. More information on the different affinities of protein A
and protein G can be found in the product information sheet from Roche Applied
Science.
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Figure legend:
Schematic diagram of sucrose density centrifugation method for isolating buoyant fractions
consisting of lipid rafts and caveolae. Homogenized cell or tissues lysates in a final
concentration of 45% sucrose are bottom loaded in an ultracentrifuge tube (see Section 3.1). A
discontinuous sucrose gradient consisting of 35% and 5% sucrose is formed on top of the sample
and the gradient is centrifuged for 16-20 hr at approximately 240,000 x g. Buoyant lipid raft and
caveolar material will float up to the 35%-5% sucrose interface while the rest of the cellular
material will remain in the 45% sucrose layer. The gradient is typically collected in 1 mL
fractions starting at the top.
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Figure 1:
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